We are live on ! Find out more
CELG.RT

Bristol-Myers Squibb Rights
CELG.RT

19 hedge funds and large institutions have $167K invested in Bristol-Myers Squibb Rights in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.01% less ownership

Funds ownership: 0.03% → 0.03% (-0.01%)

17% less capital invested

Capital invested by funds: $200K → $167K (-$33.3K)

17% less funds holding

Funds holding: 23 → 19 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$882
2
Osaic Holdings
Osaic Holdings
Arizona
+$198
3
Wells Fargo
Wells Fargo
California
+$2

Top Sellers

Rank Fund Capital Flow
1
5L
55I LLC
Massachusetts
-$13K
2
Citadel Advisors
Citadel Advisors
Florida
-$11.5K
3
PWP
Private Wealth Partners
California
-$3K
4
Koshinski Asset Management
Koshinski Asset Management
Illinois
-$300
5
UBS Group
UBS Group
Switzerland
-$28
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
FourWorld Capital Management
New York
$69K – – –
MS
2
Maven Securities
Jersey
$47K – – –
TCA
3
Transcend Capital Advisors
New Jersey
$16K – – –
DC
4
Davenport & Co
Virginia
$13K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$8K +$882 +6,672 +14%
Citadel Advisors
6
Citadel Advisors
Florida
$5K -$11.5K -87,142 -70%
UBS Group
7
UBS Group
Switzerland
$3K -$28 -209 -0.9%
Fifth Third Bancorp
8
Fifth Third Bancorp
Ohio
$3K – – –
PAG
9
Private Advisor Group
New Jersey
$2K – – –
TPA
10
Trivium Point Advisory
Connecticut
$1K – – –
5L
11
55I LLC
Massachusetts
– -$13K -86,000 Closed
PWP
12
Private Wealth Partners
California
– -$3K -20,000 Closed
Koshinski Asset Management
13
Koshinski Asset Management
Illinois
– -$300 -2,000 Closed
Bank of America
14
Bank of America
North Carolina
– -$4 -30 -2%
Wells Fargo
15
Wells Fargo
California
– +$2 +18 +180%
Osaic Holdings
16
Osaic Holdings
Arizona
– +$198 +1,500 +12,500%

CELG.RT Hedge Fund Activity: Q2 2022 in Review

19 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q2 2022, worth a combined $167K — down 17% from $200K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CELG.RT and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Susquehanna International Group, adding an estimated $882. The largest seller was 55I LLC, exiting entirely with an estimated $13K sold.

  • 19 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q2 2022, down from 23 in Q1 2022.
  • Funds reported $167K of Bristol-Myers Squibb Rights stock for Q2 2022, down 17% quarter-over-quarter.
  • 0 funds opened new Bristol-Myers Squibb Rights positions in Q2 2022 and 3 closed out, a net change of -3 holders.
  • The largest Bristol-Myers Squibb Rights buyer in Q2 2022 was Susquehanna International Group, an estimated $882 added.
  • The largest Bristol-Myers Squibb Rights seller in Q2 2022 was 55I LLC, an estimated $13K sold.

Based on aggregated 13F filings for Q2 2022.